Kircher Tilo, Alexander Nina, Bauer Michael, Dannlowski Udo, Ebner-Priemer Ulrich W, Kanske Philipp, Wöhr Markus, Pfennig Andrea
Universitätsklinik für Psychiatrie und Psychotherapie, Fachbereich Medizin, UKGM, Universität Marburg, Rudolf-Bultmann-Straße 8, 35039, Marburg, Germany.
Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Medizinische Fakultät, Technische Universität Dresden, Dresden, Germany.
Nervenarzt. 2025 Sep 12. doi: 10.1007/s00115-025-01886-8.
Major depressive disorder (MDD) and bipolar disorder (BD) are prevalent and disabling psychiatric disorders, often following a chronic and relapsing course. The Collaborative Research Centre 393 (SFB/TRR 393), funded by the German Research Foundation (DFG), aims to identify trajectories and symptom changes in MDD and BD, with a focus on cognitive-emotional mechanisms and their neurobiological underpinnings.Our research initiative seeks to (1) identify individual trajectories of recurrences and remissions in affective disorder (AD), (2) determine cognitive-emotional mechanisms and neurobiological correlates of acute symptom changes, and (3) probe mechanism-based interventions.These goals will be pursued through a threefold approach: (1) Continuous mobile assessment in a prospective cohort: We will combine in-depth clinical characterization with multilevel neuroimaging, biobanking, and -omics analyses in 1500 AD patients and healthy participants over a 2-year follow-up (German Mental Health Cohort, GEMCO) at three time points. Participants will be drawn from existing DFG FOR 2107 and BMBF Early-BipoLife cohorts (Domain A). (2) Identification of key cognitive-emotional mechanisms: We will study emotion regulation, expectation, social cognition, and cognitive-behavioural rhythms, and their neurobiological correlates mediating symptom changes, using parallel human studies and animal experiments (Domain B). (3) Targeted interventions: We will probe key cognitive-emotional mechanisms in relation to recurrences and remissions (Domain C).Over a 12-year period, we will elucidate environmental, psychosocial, and (neuro)biological predictors of illness course; cognitive-emotional and neurobehavioural mechanisms underlying real-life recurrences and remissions; and targeted, mechanism-based interventions.
重度抑郁症(MDD)和双相情感障碍(BD)是常见的致残性精神疾病,通常呈慢性复发性病程。由德国研究基金会(DFG)资助的协同研究中心393(SFB/TRR 393)旨在确定MDD和BD的病程轨迹及症状变化,重点关注认知 - 情感机制及其神经生物学基础。我们的研究计划旨在:(1)确定情感障碍(AD)复发和缓解的个体病程轨迹;(2)确定急性症状变化的认知 - 情感机制和神经生物学关联;(3)探索基于机制的干预措施。这些目标将通过三重方法来实现:(1)对前瞻性队列进行连续移动评估:在为期2年的随访中,我们将对1500名AD患者和健康参与者在三个时间点进行深入的临床特征分析,并结合多层次神经影像学、生物样本库和组学分析(德国心理健康队列,GEMCO)。参与者将从现有的DFG FOR 2107和BMBF早期双相情感障碍生活队列中选取(A领域)。(2)确定关键的认知 - 情感机制:我们将通过平行的人体研究和动物实验,研究情绪调节、期望、社会认知和认知行为节律,以及它们介导症状变化的神经生物学关联(B领域)。(3)有针对性的干预措施:我们将探究与复发和缓解相关的关键认知 - 情感机制(C领域)。在12年的时间里,我们将阐明疾病病程的环境、心理社会和(神经)生物学预测因素;现实生活中复发和缓解背后的认知 - 情感和神经行为机制;以及有针对性的、基于机制的干预措施。